Ironwood Pharmaceuticals (IRWD) Net Equity Issued and Repurchased (2012 - 2014)

Ironwood Pharmaceuticals has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at $28000.0 in Q2 2014.

• Quarterly Net Equity Issued and Repurchased fell 99.98% year-over-year to $28000.0 in Q2 2014, while the trailing twelve-month figure through Dec 2014 was $190.4 million (up 38.19% YoY) and the FY2014 annual result came in at $190.4 million, up 38.23% from the prior year.
• Net Equity Issued and Repurchased declined to $28000.0 in Q2 2014 per IRWD's latest filing, from $190.4 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $190.4 million in Q1 2014 and troughed at $28000.0 in Q2 2014.
• A 3-year average of $103.4 million and a median of $111.5 million in 2012 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 99.98% in 2014, down 99.98% in 2014.
• Over 3 years, Net Equity Issued and Repurchased stood at $85.2 million in 2012, then surged by 61.68% to $137.8 million in 2013, then tumbled by 99.98% to $28000.0 in 2014.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $28000.0, $190.4 million, and $137.8 million for Q2 2014, Q1 2014, and Q2 2013 respectively.